The dynamic interaction between symptoms and pharmacological treatment in patients with major depressive disorder: the role of network intervention analysis

Clarke DM(2009)Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence Med J Aust 190 S54-60

Currie KC(2018)Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target Pharmacol Res 130 374-384

Caraci F(2023)Physical activity and depression and anxiety disorders: a systematic review of reviews and assessment of causality AJPM Focus 2 100074-622

Spampinato SF(2020)Diet and mental health: review of the recent updates on molecular mechanisms Antioxidants 9 346-33

Morgese MG(2015)A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio really matter? Int J Food Sci Nutr 66 611-281

Tascedda F(2021)Excess mortality in depressive and anxiety disorders: the lifelines cohort study Eur Psychiatry 64 e54-654

Salluzzo MG(2014)The Burden Attributable to Mental and Substance Use Disorders as Risk Factors for Suicide: Findings from the Global Burden of Disease Study 2010 PLoS ONE 9 e91936-317

Giambirtone MC(2022)Trends in U.S. Depression prevalence from 2015 to 2020: the widening treatment gap Am J Prev Med 63 726-1586

Wanjau MN(2020)Biological and neuropsychological markers of cognitive dysfunction in unipolar vs bipolar Depression: What evidence do we have? Life Span Disabil 23 239-211

Möller H(2014)Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment Can J Psychiatry Rev Can Psychiatr 59 649-234

Clarke DM(2009)Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence Med J Aust 190 S54-60

Currie KC(2018)Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target Pharmacol Res 130 374-384

Caraci F(2023)Physical activity and depression and anxiety disorders: a systematic review of reviews and assessment of causality AJPM Focus 2 100074-622

Spampinato SF(2020)Diet and mental health: review of the recent updates on molecular mechanisms Antioxidants 9 346-33

Morgese MG(2015)A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio really matter? Int J Food Sci Nutr 66 611-281

Tascedda F(2021)Excess mortality in depressive and anxiety disorders: the lifelines cohort study Eur Psychiatry 64 e54-654

Salluzzo MG(2014)The Burden Attributable to Mental and Substance Use Disorders as Risk Factors for Suicide: Findings from the Global Burden of Disease Study 2010 PLoS ONE 9 e91936-317

Giambirtone MC(2022)Trends in U.S. Depression prevalence from 2015 to 2020: the widening treatment gap Am J Prev Med 63 726-1586

Wanjau MN(2020)Biological and neuropsychological markers of cognitive dysfunction in unipolar vs bipolar Depression: What evidence do we have? Life Span Disabil 23 239-211

Möller H(2014)Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment Can J Psychiatry Rev Can Psychiatr 59 649-234